Skip to main content

If you are having trouble viewing this message, please click here.
To ensure consistent delivery, please be sure to add us to your address book or your safe senders list.
March 14, 2018
Higher Steroids Don’t Prevent Asthma Flare-Ups in Mild/Moderate Pediatric Cases
Increasing the dose of inhaled steroids in children with mild/moderate asthma doesn’t have the desired effect and could have unintended consequences, according to a new study. Here’s why pharmacists might want to raise a red flag with with too-frequent refills.
Rare Serotonin Syndrome Shouldn’t Prohibit Depression, Migraine Treatment
More than a decade ago, the FDA cautioned about the concurrent use of drugs for depression and migraines. Now, a new study questions the guidance, noting that serotonin syndrome—the potential risk—is very rare. Here are the details.
Metformin Use During Pregnancy Might Increase Offspring Weight Issues
Metformin prescriptions for pregnant women are on the increase, with growing diagnoses of polycystic ovary syndrome and gestational diabetes. The concern, however, is that the commonly prescribed drug can increase the risk of being overweight or obese for the offspring, a new study suggests. Here is more information for pharmacists.
Small Study Reports Troubling Abuse Potential for Gabapentin
Gabapentin is recommended as an alternative to avoid overuse of opioids for pain control. A new study suggests, however, that the drug is also being misused. Find out how researchers came to that conclusion.
Connect With U.S. Pharmacist

U.S. Pharmacist Weekly News Update is a service of Jobson Medical Information LLC
the publisher of U.S. Pharmacist, 160 Chubb Avenue, Suite 304, Lyndhurst, NJ 07071.
To change your address, reply to this message and give us your old and new addresses.
Type "Change of Address: U.S. Pharmacist Case Study Challenge" in the subject line.
Click here if you do not want to receive future emails from U.S. Pharmacist Weekly News Update.

Comments

Popular posts from this blog

ADMELOG A NEW INSULIN  LISPRO OPTION A MEALTIME INSULIN highly similar to Humalog ® in structure, pharmacology, efficacy, safety, and dosing 1-4 FOR DETAILS, VISIT ADMELOGPRO.COM Indication for ADMELOG ® (insulin lispro injection) 100 Units/mL ADMELOG is a rapid-acting human insulin analog indicated to improve glycemic control in adults with type 2 diabetes and adults and children (3 years and older) with type 1 diabetes. Important Safety Information for ADMELOG ® (insulin lispro injection) 100 Units/mL CONTRAINDICATIONS ADMELOG is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin lispro or to any of its excipients. WARNINGS AND PRECAUTIONS Insulin pens and needles must never be shared between patients, even if the needle ...
Recommend OneTouch ® meters with confidence. We’re here to help your patients by offering the lowest co-pay on the most health plans. ‡ * Covered: For most plans, products that are generally available and reimbursed. † Medical exception may apply. ‡ Some health plans may have more than one brand available at the lowest co-pay. The information provided is not a guarantee of coverage or payment. Actual benefits are determined by each plan in accordance with its respective policies and procedures. All trademarks are the property of their respective owners. © 2018 LifeScan, Inc.   NACO/OTB/1016/0468c...